Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VECTTOR Technologies is a medical device company that develops and commercializes advanced electro-stimulation systems for the treatment of chronic pain. The company's core technology, the VECTTOR system, utilizes interference therapy to stimulate the autonomic nervous system and promote the production of neuropeptides like endorphins and enkephalins. Unlike traditional TENS units, VECTTOR is designed to address the underlying physiological causes of pain by improving circulation and cellular regeneration. The system is FDA-cleared and used for a variety of conditions, including fibromyalgia, diabetic neuropathy, and complex regional pain syndrome. The technology is based on the clinical research of Dr. Donald Rhodes and aims to provide a non-invasive, drug-free alternative for patients with debilitating pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VECTTOR Technologies.